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in Australia. There are two major evolutionary changes observed due to increased vaccine selection pressure: ACV allelic divergence and inactivation of ACV antigen expression ( Figure 2 ).
The greatest ACV allelic divergence is seen in ptxA and prn alleles.
SNP cluster I carries the prn2 and ptxA1 alleles which encode antigenic variants that differ from the prn1 and ptxA2 alleles in Tohama I, the strain used to produce the WCV and ACV. The ptxA1
allele emerged prior to the introduction of WCV but only expanded after WCVs were used 4 and is present in all cluster I-IV strains.
Similarly the prn2 allele emerged during the WCV period in SNP cluster I but expanded after the introduction of ACV 4 . These mutations in ptxA1 and prn2 alter amino acid residues in known B/T immune epitopes thereby altering recognition from ACVgenerated immunity 4, 10 . A double allelic exchange mutant of ACV alleles prn1 and ptxA2 with non-ACV alleles prn2 and ptxA1 conferred a greater survival rate in ACV immunised mice than the wild type strain demonstrating the selective advantage of antigen mismatch in a highly vaccinated environment 11 .
Besides mismatches in ACV antigens, the current predominance of SNP cluster I is also associated with carrying the ptxP3 allele which encodes a variant pertussis toxin promoter 12 . This new promoter is associated with increased pertussis toxin production, and possibly virulence and disease severity compared with strains carrying the original ptxP1 allele 13, 14 . Increased pertussis toxin production is thought to provide a selective advantage by delaying neutrophil recruitment and modulating the immune response 15 . Using a mixed-infection mouse model, SNP cluster I strains outcompeted SNP cluster II strains (carrying ptxP1, prn3 and ptxA1) in a vaccinated environment 16 . This demonstrates that these genomic changes have increased the overall fitness of the circulating population of B. pertussis and contribute to the predominance of SNP cluster I in an ACV environment.
Recently, strains which do not express ACV antigens have emerged in many developed countries, most notably the Prn deficient strains 5, 6, 17 . In Australia, Prn deficient strains are primarily found in SNP cluster I and were first detected at the start of the 2008 epidemic, making up 5% of strains isolated 18 . However, within a decade this increased to 90% by 2017, the highest proportion of Prn deficient strains in the world 3 . Over 20 independent mechanisms for Prn inactivation have been documented 5, 6, 18 . This diversity of inactivation suggests a beneficial selection pressure for convergent evolution and that Prn deficient strains emerged independently from multiple different clones 19 . Findings from multiple mouse studies support increased fitness for losing pertactin in an ACV environment with higher survival of Prn deficient strains compared to Prn producing strains in ACV-vaccinated mouse 20, 21 . Prn deficient strains also displayed no differences in disease severity compared to Prn producing strains but have a higher likelihood to cause disease and persist longer in ACV vaccinated individuals 14, 22 . Furthermore, in a mixed infection mouse model, Prn deficient strains had poorer survival in unvaccinated mice compared to Prn producing strains therefore providing evidence that Prn inactivation is an ACV-driven phenomenon. Finally, inactivation of Fha has also been detected in Australia 3 while Ptx inactivation has been reported in other countries 17 . However, these mutant strains are rare, and it remains to be seen whether the loss of these virulence factors increases the fitness of B. pertussis in an ACV environment.
Proteomic changes and broadening the view of pathogen adaptation to vaccination
In addition to increased fitness in an ACV environment, it was shown that SNP cluster I also outcompetes SNP cluster II in an unvaccinated environment 16 . This suggests that there are other changes between the two clusters that contribute to the current predominance of SNP cluster I in Australia. In proteomic studies, our laboratory identified increased expression of previously unknown adaptations in SNP cluster I of reduced expression of immunogenic proteins such as the type III secretion system and upregulation of amino acid and metal ion transport proteins and adhesins 23, 24 (Figure 2 ). Some of these proteomic differences were associated with genetic mutations which are also found in other global pertussis strains 23 . Additionally, several other transcriptomic studies have reported gene expression differences associated with the current epidemic pertussis strains 25, 26 . Together, these studies have broadened our understanding of how B. pertussis is evolving and identified additional pathogen factors important for the reemergence of pertussis.
Future strategies to reduce the burden of pertussis
The ongoing evolution of B. pertussis in response to vaccine selection requires continued long-term epidemiological surveillance in Australia to monitor vaccine escape strains and the possible introduction of emerging antibiotic resistant B. pertussis strains from other countries 27 . Although B. pertussis is adapting to the ACV, the current ACV remains effective in preventing pertussis disease in fully immunised individuals 28 . Additionally, maternal immunisation and cocooning are also effective strategies at protecting the most vulnerable newborns from pertussis 29, 30 . However, for long term prevention and protection, an improved vaccine is required in the future. Current proposed strategies to alter
In Focus vaccine alleles to better match SNP cluster I will improve our ability to target these strains but will not be sufficient to combat Prn deficient strains. Therefore, a future pertussis vaccine should broaden the number of antigens targeted and ensure that these antigens are essential to B. pertussis survival so as to limit further pathogen adaptation. To do this, further research is required to better understand fundamental aspects of pertussis biology and adaptation as well as the processes behind vaccine and hostinduced immunity.
Conflicts of interest
The author declares no conflicts of interest.
